Shandong Keyuan Pharmaceutical Co., Ltd is a high technology enterprise mainly focuses on the development, manufacture and sales of APIs. With years of experience in API field, Keyuan Pharm has become a pioneer with the support from its key products: Gliclazide, Isosorbide Mononitrate, Isoflurane, Xanthinol Nicotinate, 3-Amino-3-Azabicyclo [3.3.0] Octane, Clarithromycin Lactobionate, Metformin Hydrochloride, Ropivacaine Hydrochloride, Esmolol Hydrochloride, etc.
With the goal of becoming a leading player in the manufacturing of anti-diabetes, cardiovascular and inhalent anesthetics APIs, Keyuan Pharm will contribute more to the development of national pharmaceutical industry.

Shandong Keyuan Pharmaceutical Co., Ltd is a high technology enterprise mainly focused on the development, manufacture and marketing of Active Pharmaceutical ingredients (APIs). As a result of the strategic cooperation between Linuo Group and Shandong Pharmaceutical Industrial Research institute (SDPIRI), Keyuan Pharm heritages the innovative spirit from its parent company. When it was founded in July 1992, it was only a medium trial base under SDPIRI while the new GMP plant with total investment of millions of US dollars in Shanghe County marks the new stage of its development. In May 2004, we received the GMP certificates for the 15 APIs manufactured in the new plant. In 2005, we received the GMP certificates for the 4 new products.
With years of experience in API field, Keyuan Pharm has become a pioneer with the support from its key products: Gliclazide, Isosorbide Mononitrate, Isoflurane, Xanthinol Nicotinate, 3-Amino-3-Azabicyclo [3.3.0] Octane, Clarithromycin Lactobionate, Metformin Hydrochloride, Ropivacaine Hydrochloride, etc.
With the goal of becoming a leading player in the manufacturing of anti-diabetes, cardiovascular and inhalent anesthetics APIs, Keyuan Pharm will contribute more to the development of national pharmaceutical industry.